AbbVie announced that the FDA has approved JUVMO (tavapadon) tablets as the first and only selective D1/D5 receptor agonist for the treatment of adults with Parkinson’s disease, a progressive… read more.
JCR Pharmaceuticals Co., Ltd. announced that the Ministry of Health, Labour and Welfare of Japan granted orphan drug designation to givinostat, an investigational drug for the treatment of… read more.
Researchers from Oxford Population Health analysed clinic blood pressure measurements collected by Our Future Health, the UK’s largest health research programme, from participants who enrolled between 2022 and… read more.
Most medical devices do not hit the market through rigorous safety testing but by being deemed similar enough to something already approved—the “predicate” device through a mechanism known… read more.
Merck, known as MSD outside of the United States and Canada, and Eisai announced the FDA has approved the dual oral regimen of WELIREG (belzutifan), Merck’s first-in-class oral… read more.
Eli Lilly and Company announced that the FDA approved Olumiant (baricitinib), a once-daily pill, for the treatment of pediatric patients 12 years of age and older with severe… read more.
Eli Lilly and Company announced the FDA approval of Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin, indicated along with diet and exercise to control high blood sugar in adults… read more.
Communicating normal test results that reveal no abnormalities isn’t always enough to ease a patient’s worries. In this study, researchers asked 349 participants to imagine having gastrointestinal symptoms… read more.
Pharmacies that receive federal funds must provide language support to make sure patients can understand their medication instructions. A survey of 169 outpatient prescribers at a large academic… read more.
Pharming announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) seeking approval for lower doses of Joenja (leniolisib), an oral,… read more.
Emergency medicine physician-researchers at the University of Cincinnati have shown that a targeted quality improvement campaign can safely reduce unnecessary head and cervical spine (neck) computed tomography (CT) scans in… read more.
Dr. Wendy Harpham was 36 years old and a successful physician who prided herself on her empathy. Then she was diagnosed with cancer. Seeing things from the other… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
